Compounds comprising curcumin and basic amino acids
MX2018007297A
Pharmaceutical composition of a meglitinide and a biguanide.
MX2018004788A
New rifaximin solid phases.
MX2017017151A
Novel solid phases for inhibitors of the bone resorption.
MX2017005639A
Pharmaceutical compositions comprising a combination of clindamycin and butoconazole, and their use.
MX2016016260A
New solid forms of sitagliptin.
MX2016008646A
Solid forms of desvenlafaxine.
MX2015003939A
Pharmaceutical composition and combination containing an antimicrobial and an antimycotic.
MX2015003937A
Pharmaceutical composition including a non-sedating antihistaminic and an anti-inflammatory immunosuppressant.
MX2015002718A
Solid pharmaceutical composition with non-sedating antihistamine and decongestant.
MX2013015100A
Synergistic combination for treating hypertension.
MX2013009849A
Capsule with liquid content including an anti-inflammatory.
MX2013009450A
Laxative composition used in constipation.
MX2013006980A
Composition with a proton-pump inhibitor and an h2 antagonist.
MX2013006332A
Oral pharmaceutical compositions for use in dyslipidemias.
MX2012014757A
Pharmaceutical composition comprising a meglitinide and a thiazolidinedione or pharmaceutically acceptable salts, thereof and use of the same.
MX2012014498A
Rosuvastatin pharmaceutical composition.
MXPA05000484A
Stable combination of enrofloxacin and piroxicam, pharmaceutical compositions comprising the same, process for the obtention thereof, and its veterinary use.
EP1712229A1
Fluconazole-tinidazole combination for the treatment of vaginal infections, composition thereof and preparation and use of same
MXPA02010932A
Procedure for the preparation of meloxicam micro-spheres (4-hydroxy-2-methy-n-(5-methyl-2- thiazolyl)-2h-1,2- benzothiazine -3- carboxamide -1,1- dioxide) with negative floatability.